US tracker

H.R. 8205

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Energy and Commerce Committee · Rep. Mike Quigley (D-IL)

28 September 2026 | Passed Senate (voice vote)

What's next: Presidential review (±10 days)

Summary: The bill would extend funding through fiscal year 2031 for federal programs supporting research and development of treatments for ALS and other neurodegenerative diseases, including grants from the National Institutes of Health and Food and Drug Administration, as well as a partnership between the two agencies. It would also require the NIH to evaluate the safety and efficacy of experimental drugs and mandate that researchers report serious side effects, while directing the FDA to develop and publish a five-year plan to advance drug development and expand access to investigational treatments for these diseases.

[AI-Generated]

Posted 29 September 2026

As published — the exact text this tracker posted, kept verbatim for the record

H.R. 8205 | Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 | Rep. Mike Quigley (D-IL) | Energy and Commerce Committee 📅 28 September 2026 | ✅🏛️ Passed Senate (voice vote) What's next: Presidential review (±10 days) Summary: The bill would extend funding through fiscal year 2031 for federal programs supporting research and development of treatments for ALS and other neurodegenerative diseases, including grants from the National Institutes of Health and Food and Drug Administration, as well as a partnership between the two agencies. It would also require the NIH to evaluate the safety and efficacy of experimental drugs and mandate that researchers report serious side effects, while directing the FDA to develop and publish a five-year plan to advance drug development and expand access to investigational treatments for these diseases. [AI-Generated]

Look it up on Congress.gov See the full path of H.R. 8205

A permanent record of a post published by BillTracking's US tracker. The facts are drawn from the official record; the reference above is the lookup key on Congress.gov. Spotted an error? accuracy@billtracking.org.